B Runmarker - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B Runmarker

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosisO Andersen, J Lycke, P O Tollesson, et al.

Acta Neurologica Scandinavica|July 26, 2017

Diffusion tensor imaging in multiple sclerosis at different final outcomesO Andersen, A Hildeman, M Longfils, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosisO Andersen, J Lycke, P O Tollesson, et al.

Acta Neurologica Scandinavica|July 26, 2017

Diffusion tensor imaging in multiple sclerosis at different final outcomesO Andersen, A Hildeman, M Longfils, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.

Pageof 2